Esomeprazole Magnesium Oral Suspension Recalled for Failed Impurity Specifications
Zydus Pharmaceuticals is recalling Esomeprazole Magnesium 40 mg delayed-release oral suspension because out-of-specification test results were found for unknown degradation products during stability testing.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall with an out-of-specification degradation product issue in a prescription drug affecting patient safety and product integrity, meeting the criteria for a Severe rating.
Plain-English summary
Zydus Pharmaceuticals (USA) Inc. is recalling Esomeprazole Magnesium (Esomeprazole Magnesium) delayed-release oral suspension, 40 mg, supplied in 30-count single-dose packets per carton. The recall affects lot numbers M311638 (Exp 07/2025), M400374 (Exp 10/2025), M402496 (Exp 02/2026), M407998 (Exp 05/2026), M502247 (Exp 11/2026), M414770, and M414512 (Exp 09/2026), with a total of 30,674 cartons distributed nationwide in the USA.
The recall was initiated due to failed impurities and degradation specifications. Out-of-specification test results were obtained for unknown individual degradation products during related compounds testing in long-term stability studies.
Consumers taking this medication should contact their healthcare provider or pharmacist before discontinuing use or to discuss alternative treatment options. Patients should not stop taking their medication abruptly without consulting their healthcare provider. Inquiries can be directed to Zydus Pharmaceuticals (USA) Inc. at the contact information provided by the FDA.
The recalled product
- Product
- ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)
- Brand
- ESOMEPRAZOLE MAGNESIUM
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Hazard
- degradation-product
- failed-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot # M311638
- Exp 07/2025
- M400374
- Exp 10/2025
- M402496
- Exp 02/2026
- M407998
- Exp 05/2026
- M502247
- Exp 11/2026
- M414770
- M414512
- Exp 09/2026.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ESOMEPRAZOLE MAGNESIUM
- ModerateEsomeprazole Magnesium oral suspension recalled for failed impurity specifications
FDA (Drugs) · 2025-05-28
- ModeratePrescription drug esomeprazole magnesium recalled for labeling error
FDA (Drugs) · 2024-12-11
- ModeratePrescription esomeprazole magnesium capsules recalled for failed impurity specifications
FDA (Drugs) · 2023-11-29
- ModeratePrescription Drug Esomeprazole Out of Specification for Potency
FDA (Drugs) · 2022-10-05
- ModerateEsomeprazole Magnesium Capsules Recalled for Out-of-Specification Potency
FDA (Drugs) · 2022-10-05
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22